Literature DB >> 12944057

Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

Ugo Pastorino1, Massimo Bellomi, Claudio Landoni, Elvio De Fiori, Patrizia Arnaldi, Maria Picchio, Giuseppe Pelosi, Peter Boyle, Ferruccio Fazio.   

Abstract

BACKGROUND: Low-dose spiral CT of the chest effectively detects early-stage lung cancer in high-risk individuals. The high rate of benign nodules and issues of making a differential diagnosis are critical factors that currently hamper introduction of large-scale screening programmes. We investigated the efficacy of repeated yearly spiral CT and selective use of positron emission tomography (PET) in a large cohort of high-risk volunteers.
METHODS: We enrolled 1035 individuals aged 50 years or older who had smoked for 20 pack-years or more. All patients underwent annual low-dose CT, with or without PET, for 5 years. Lesions up to 5 mm were deemed non-suspicious and low-dose CT was repeated after 12 months (year 2).
FINDINGS: By year 2, 22 cases of lung cancer had been diagnosed (11 at baseline, 11 at year 2). 440 lung lesions were identified in 298 (29%) participants, and 95 were recalled for high-resolution contrast CT. PET scans were positive in 18 of 20 of the identified cancer cases. Six patients underwent surgical biopsy for benign disease because of false-positive results (6% of recalls, 22% of invasive procedures). Complete resection was achieved in 21 (95%) lung cancers, 17 (77%) were pathological stage I (100% at year 2), and the mean tumour size was 18 mm. There were no interval lung cancers in the 2.5 years of follow-up (average time on study from randomisation to last contact), although 19 individuals were diagnosed with another form of cancer (two deaths and 17 non-fatal admissions).
INTERPRETATION: Combined use of low-dose spiral CT and selective PET effectively detects early lung cancer. Lesions up to 5 mm can be checked again at 12 months without major risks of progression.

Entities:  

Mesh:

Year:  2003        PMID: 12944057     DOI: 10.1016/S0140-6736(03)14188-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  97 in total

Review 1.  Interventional Pulmonology: A Brave New World.

Authors:  Hardeep S Kalsi; Ricky Thakrar; Andre F Gosling; Shahzad Shaefi; Neal Navani
Journal:  Thorac Surg Clin       Date:  2020-08       Impact factor: 1.750

Review 2.  Screening for lung cancer using low-dose spiral CT: 10 years later, state of the art.

Authors:  M Zompatori; M Mascalchi; F Ciccarese; N Sverzellati; U Pastorino
Journal:  Radiol Med       Date:  2012-06-28       Impact factor: 3.469

Review 3.  Lung cancer screening: an update, discussion, and look ahead.

Authors:  Peter J Mazzone
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.075

4.  Video-assisted thoracoscopic lobectomy with a single utility port is feasible in the treatment of elderly patients with peripheral lung cancer.

Authors:  Chang Li; Chun Xu; Haitao Ma; Bin Ni; Jun Chen; Tengfei Chen; Hongtao Zhang; Jun Zhao
Journal:  Thorac Cancer       Date:  2014-04-22       Impact factor: 3.500

5.  Solitary pulmonary nodule: detection and management.

Authors:  S Diederich; M Das
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

6.  Screening for lung cancer using low dose CT scanning: results of 2 year follow up.

Authors:  R MacRedmond; G McVey; M Lee; R W Costello; D Kenny; C Foley; P M Logan
Journal:  Thorax       Date:  2006-01       Impact factor: 9.139

7.  Detection of pulmonary nodules at multirow-detector CT: effectiveness of double reading to improve sensitivity at standard-dose and low-dose chest CT.

Authors:  Dag Wormanns; Karl Ludwig; Florian Beyer; Walter Heindel; Stefan Diederich
Journal:  Eur Radiol       Date:  2004-11-04       Impact factor: 5.315

8.  Is whole-body FDG-PET valuable for health screening? Against.

Authors:  Matthias Weckesser; Otmar Schober
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

9.  Resolving small pulmonary nodules: CT features.

Authors:  S Diederich; J Hansen; D Wormanns
Journal:  Eur Radiol       Date:  2005-07-08       Impact factor: 5.315

Review 10.  Unleashing the power of proteomics to develop blood-based cancer markers.

Authors:  Ayumu Taguchi; Samir M Hanash
Journal:  Clin Chem       Date:  2012-10-24       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.